Conclusion: The findings of the present pilot study indicate that oral lactulose has no beneficial effects in IBD patients in particular with regard to clinical activity, endoscopic score or ...
In clinical studies, the most common adverse reactions for XIFAXAN (alone or in combination with lactulose ... and potassium chloride for oral solution) is a prescription medication used by ...
In conclusion, our present pilot study indicates that oral lactulose has no beneficial effects in IBD patients. For sure, a randomized placebo-controlled trial is currently underway to confirm ...